Contact us

877-469-1TRM
424-208-8866

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer (SUNRISE)

SUNRISE: A Phase III, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Bavituximab Plus Docetaxel Versus Docetaxel Alone as Second-Line Therapy in Patients With Stage IIIb/IV Non-Squamous Non Small-Cell Lung Cancer

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Non-Small-Cell Lung Cancer Stage IIIB Bavituximab III Open and Accruing